Literature DB >> 34134860

"Sobriety equals getting rid of hepatitis C": A qualitative study exploring the interplay of substance use disorder and hepatitis C among hospitalized adults.

Taylor A Vega1, Ximena A Levander2, Andrew Seaman3, P Todd Korthuis4, Honora Englander5.   

Abstract

BACKGROUND: People who use drugs (PWUD) commonly experience complex illness, psychosocial stressors, housing insecurity, and stigma, which may play key roles in their struggles with addiction. In a study of hospitalized PWUD with hepatitis C virus infection (HCV), participants described treating HCV as "part of recovery." These findings led us to explore how hospitalization and acute illness altered patients' perceptions of substance use disorder (SUD) and HCV.
METHODS: Researchers audio recorded in-depth semi-structured individual interviews of 27 hospitalized adults with SUD and HCV seen by an addiction consult service (ACS) at an urban academic medical center between June and November 2019. Research staff transcribed interviews and dual coded them deductively and inductively at the semantic level. Researchers used a matrix visualization to discern relationships among codes and conducted a thematic analysis.
RESULTS: Many participants believed addictions treatment should precede an HCV cure for varying reasons. Some wanted to avoid reinfection; others believed "getting clean" afforded the mental clarity to address health issues, including HCV. Patients newly engaged in SUD treatment described HCV treatment as a "step towards recovery" and could serve as motivation to continue SUD treatment. Participants believed HCV cure could facilitate sobriety by "mentally putting drugs in the past" and was a future-oriented action toward "better health." Many participants described the compounded stigma of having HCV infection and SUD by multiple groups, including friends/family who do not use drugs, other drug users, and health care workers.
CONCLUSION: Hospitalized adults with SUD and HCV believed addictions engagement should precede HCV treatment and HCV cure could play an important role in their "recovery" journey. Discussing HCV treatment during hospitalization may be an opportunity to support engagement in SUD treatment and targets an untreated patient population critical for achieving HCV elimination.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatitis C virus; Hospital; Qualitative research; Substance-related disorders

Mesh:

Year:  2021        PMID: 34134860      PMCID: PMC8217723          DOI: 10.1016/j.jsat.2021.108337

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  31 in total

1.  Co-Located hepatitis C virus infection treatment within an opioid treatment program promotes opioid agonist treatment retention.

Authors:  Brooke Severe; Jeanette M Tetrault; Lynn Madden; Robert Heimer
Journal:  Drug Alcohol Depend       Date:  2020-06-12       Impact factor: 4.492

2.  Structural Vulnerability: Operationalizing the Concept to Address Health Disparities in Clinical Care.

Authors:  Philippe Bourgois; Seth M Holmes; Kim Sue; James Quesada
Journal:  Acad Med       Date:  2017-03       Impact factor: 6.893

3.  HIV care cascade before and after hospitalization: impact of a multidisciplinary inpatient team in the US South.

Authors:  A E Nijhawan; M Bhattatiry; M Chansard; S Zhang; E A Halm
Journal:  AIDS Care       Date:  2019-12-06

4.  Evaluation of contingency management as a strategy to improve HCV linkage to care and treatment in persons attending needle and syringe programs: A pilot study.

Authors:  B L Norton; M A Bachhuber; R Singh; L Agyemang; J H Arnsten; C O Cunningham; A H Litwin
Journal:  Int J Drug Policy       Date:  2019-04-16

5.  "We've Learned It's a Medical Illness, Not a Moral Choice": Qualitative Study of the Effects of a Multicomponent Addiction Intervention on Hospital Providers' Attitudes and Experiences.

Authors:  Honora Englander; Devin Collins; Sylvia Peterson Perry; Molly Rabinowitz; Elena Phoutrides; Christina Nicolaidis
Journal:  J Hosp Med       Date:  2018-04-25       Impact factor: 2.960

6.  Predictors of Opioid and Alcohol Pharmacotherapy Initiation at Hospital Discharge Among Patients Seen by an Inpatient Addiction Consult Service.

Authors:  Honora Englander; Caroline King; Christina Nicolaidis; Devin Collins; Alisa Patten; Jessica Gregg; P Todd Korthuis
Journal:  J Addict Med       Date:  2020 Sep/Oct       Impact factor: 3.702

7.  Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study.

Authors:  Alain H Litwin; John Jost; Katherine Wagner; Moonseong Heo; Alison Karasz; Judith Feinberg; Arthur Y Kim; Paula J Lum; Shruti H Mehta; Lynn E Taylor; Judith I Tsui; Irene Pericot-Valverde; Kimberly Page
Journal:  Contemp Clin Trials       Date:  2019-10-24       Impact factor: 2.226

8.  Problem opioid use and HIV primary care engagement among hospitalized people who use drugs and/or alcohol.

Authors:  Lacey Critchley; Adam Carrico; Natalie Gukasyan; Petra Jacobs; Raul N Mandler; Allan E Rodriguez; Carlos Del Rio; Lisa R Metsch; Daniel J Feaster
Journal:  Addict Sci Clin Pract       Date:  2020-06-19

9.  Stigma as a fundamental hindrance to the United States opioid overdose crisis response.

Authors:  Alexander C Tsai; Mathew V Kiang; Michael L Barnett; Leo Beletsky; Katherine M Keyes; Emma E McGinty; Laramie R Smith; Steffanie A Strathdee; Sarah E Wakeman; Atheendar S Venkataramani
Journal:  PLoS Med       Date:  2019-11-26       Impact factor: 11.069

Review 10.  Hepatitis C elimination: challenges with under-diagnosis and under-treatment.

Authors:  Norah A Terrault
Journal:  F1000Res       Date:  2019-01-14
View more
  2 in total

1.  Hepatitis C cure as a 'gathering': Attending to the social and material relations of hepatitis C treatment.

Authors:  Adrian Farrugia; Renae Fomiatti; Suzanne Fraser; David Moore; Michael Edwards; Elizabeth Birbilis; Carla Treloar
Journal:  Sociol Health Illn       Date:  2022-04-01

2.  Exploring how hospitalization can alter hepatitis c virus treatment prioritization and trajectories in people who use drugs: A qualitative analysis.

Authors:  Ximena A Levander; Taylor A Vega; Andrew Seaman; P Todd Korthuis; Honora Englander
Journal:  Subst Abus       Date:  2021-06-23       Impact factor: 3.716

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.